期刊文献+

人群影响指标的概念及应用 被引量:2

Definition and Application of Population Impact Measures
原文传递
导出
摘要 本文阐述了人群影响指标(PIMs)的定义和应用。PIMs借鉴了需要治疗人数(NNT)的概念,将临床指标扩展到人群,衡量某一个干预措施实施后在人群中的效果或某一危险因素对于人群的危害,为卫生政策的制定提供循证证据。衡量干预措施有效性的人群影响指标有:疾病影响人数、人群影响人数和人群预防人数。衡量危险因素有害性的人群影响指标有:暴露影响人数、暴露病例影响人数、人群影响人数、病例影响人数和消除风险t年后的人群影响人数。 This paper is aimed to introduce the definition and application of Population Impact Measures(PIMs).The PIMs use Number Need to Treat(NNT) for reference and generalize the variables of clinical research to interest population,which then can be used to measure the effectiveness of interventions and the harmfulness of risk factors,so as to provide evidence for making public health policy.Of the PIMs,the variables used for measuring the effectiveness of interventions include Disease Impact Number(DIN),Population Impact Number(PIN) and Number of Events Prevented in your Population(NEPP);The variables used for measuring the harmfulness of risk factors include Exposure Impact Number(EIN),Exposed Cases Impact Number(ECIN),Population Impact Number(PIN),Case Impact Number(CIN) and Population Impact Number of Eliminating a Risk factor(PIN-ER-t).
出处 《中国循证医学杂志》 CSCD 2012年第5期614-618,共5页 Chinese Journal of Evidence-based Medicine
关键词 人群影响指标 疾病影响人数 人群影响人数 人群预防人数 暴露影响人数 暴露病例影响人数 病例影响人数 消除风险t年后的人群影响人数 Population Impact Measures Disease Impact Number Population Impact Number Number of Events Prevented in your Population Exposure Impact Number Exposure Case Impact Number Exposure Impact Number Population Impact Number of Eliminating a Risk factor
  • 相关文献

参考文献12

  • 1Heller RF, Page J. A population perspective to evidence based medicine: "evidence for population health", l Epidemiol Community Health, 2002, 56(1): 45-47.
  • 2Perez L, Kunzli N. From measures of effects to measures of potential impact. Int J Public Health, 2009, 54(1): 45-48.
  • 3Khoury MJ, Gwinn M, Ioannidis JP. The emergence of translational epidemiology: from scientific discovery to population health impact. AmJ Epidemiol, 2010, 172(5): 517-524.
  • 4Briss PA, Evidence-based: US road and public-health side of the street. Lancet, 2005, 365(9462): 828-830.
  • 5俞卫.美国医改新动态:疗效比较研究启动[J].中国卫生,2009(11):78-80. 被引量:2
  • 6吴泰相,刘关键.NNT和NNH的概念及应用[J].中国循证医学杂志,2007,7(9):669-672. 被引量:10
  • 7Heller RF, Dobson AJ. Disease impact number and population impact number: population perspectives to measures of risk and benefit. BMJ, 2000, 321(7266): 950-953.
  • 8Heller RF, Dobson AJ, Atria J, et al. Impact numbers: measures of risk factor impact on the whole population from case-control and cohort studies. J Epidemiol Community Health, 2002, 56(8): 606-610.
  • 9Heller RF, Edwards R, McElduff P. Implementing guidelines in primary care: can population impact measures help? BMC Public Health, 2003, 3: 7.
  • 10Heller RF, Buchan I, Edwards R, et al. Communicating risks at the population level: application of population impact numbers. BMJ, 2003, 327(7424): 1162-1165.

二级参考文献5

  • 1吴泰相,刘关键,张鸣敏,王覃,倪娟,魏家富,周礼鲲,段鑫,陈小燕,郑洁,乔杰奇.青蒿素类药物预防日本血吸虫感染效果及安全性的系统评价[J].中华医学杂志,2003,83(14):1219-1224. 被引量:11
  • 2Andreas L,David L,Sackett RS,et al.An assessment of clinically useful measures of the consequences of treatment.The New Eng J Med,1988,318(26):1728-1733.
  • 3Fletcher RH,Fletcher SW,Wagner EH.Clinical Epidemiology.The Essentials.3rd edition.Williams & Wilkins A Waverly Company.Baltimore,Maryland,USA.
  • 4Gordon Guyatt,Drummond Rennie.Users' Guides to the medical literature.Essentials of Evidence-Based Clinical Practice.JAMA ARCHIVES JORNALS.AMA Press.
  • 5Johansen HK,Gotzsche PC.Amphotericin B versus fluconazole for controlling fungal infections in neutropeniccancer patients.Cochrane Database of SystematicReviews,Issue 2,2002,(2):CD000239.

共引文献10

同被引文献15

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部